SCHEMBL30103165

SCHEMBL30103165

COc1cc(F)cc(-c2cnc(CCl)cn2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 2/20 0.47
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CYP1A1 P04798 3/20 0.39
▸ CYP1B1 Q16678 3/20 0.39
▸ LRRK2 Q5S007 3/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ LDHA P00338 1/20 0.37
▸ FGFR1 P11362 2/20 0.35
▸ FGFR2 P21802 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2E1 P05181 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C8 P10632 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2A6 P11509 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP4B1 P13584 1/20 0.35
▸ CYP2B6 P20813 1/20 0.35
▸ CYP3A5 P20815 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24785105 1.00 KDM1A (0.47) KDM1ANPC1RAB9ACYP1A1CYP1B1
SCHEMBL30103132 0.86 KDM1A (0.47) KDM1ANPC1RAB9ACYP1A1CYP1B1
SCHEMBL24785377 0.86 KDM1A (0.47) KDM1ANPC1RAB9ACYP1A1CYP1B1
SCHEMBL24784622 0.75 P2RX7 (0.40) KDM1ANPC1RAB9ALDHAFGFR1
SCHEMBL24785335 0.75 KDM1A (0.41) KDM1ANPC1RAB9ACYP1A1CYP1B1
SCHEMBL30103062 0.73 KDM1A (0.49) KDM1AGRM5KDM4ETDP1FYN
SCHEMBL30103128 0.73 ALDH1A1 (0.47) NPC1RAB9ACYP1A2CYP3A4CYP2C19
SCHEMBL24785826 0.73 KDM1A (0.49) KDM1AGRM5KDM4ETDP1FYN
SCHEMBL24785814 0.73 ALDH1A1 (0.47) NPC1RAB9ACYP1A2CYP3A4CYP2C19
SCHEMBL30915012 0.73 HPGDS (0.46) KDM4EMAPTFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448913-A Bicyclic compounds for the treatment of EP2, EP4 receptor mediated diseases 武汉人福创新药物研发中心有限公司 2022-12-09 — — CN disclosed
Send feedback